Skip to content

Emergency Department Management of Femur Fractures

Emergency Department Management of Isolated Femur Fracture Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06531564
Enrollment
155
Registered
2024-08-01
Start date
2023-08-01
Completion date
2024-02-01
Last updated
2024-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Femur Fracture, Pain, Joint

Keywords

isolated femur fracture, analgesia, emergency department, nerve block

Brief summary

Comparison of emergency department management of patients presenting with isolated hip fracture: comparison of methods used in pain management, monitoring, and treatment; comparison of hospitalization durations; comparison of mortality

Detailed description

Patient demographics, mechanism of injury, femur fracture classification, associated treatments, pre-procedural pain scoring, post-procedural pain scoring, orthopedic consultation, and patient outcomes (discharge, admission to ward or ICU, mortality) will be recorded on the data form. For acute pain management, the timing of treatment administration, effectiveness of the applied method based on pre- and post-procedural pain scoring systems will be assessed. Post-procedural pain scores will be collected at 30, 60, and 120 minutes. Long-term complications as a result of hospitalization following emergency department follow-ups will include monitoring on days 7 and 21 for mortality and morbidity. The patients will be analyzed in 5 groups based on the treatments administered in the emergency department. 1. IV Opioid 2. IV NSAID 3. IV acetaminophen 4. Femoral nerve block 5. PENG block The researcher will not interfere with the treatment decision made by the responsible physician or the treatment process

Interventions

None listed

Sponsors

Ankara Etlik City Hospital
CollaboratorOTHER_GOV
Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

Patients over the age of 18 years

Exclusion criteria

Forensic cases Patients who do not have follow-up in our healthcare system or cannot be followed up Patients with allergies to opioids or local anesthetics Patients with suspected neuropathy among defined complications of diabetes mellitus Patients requiring treatment for ≥2 different types of fractures upon emergency department admission

Design outcomes

Primary

MeasureTime frameDescription
effective analgesia after receiving treatment24 hourspatients will be evaluated before and after analgesic treatments according to pain scales ( visual analogue scale, verbal pain intensity scale, PAINAD ( pain assessment in advanced dementia) scale andvisual analogue scale), effective pain management will be primary outcome

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026